The Evolution of Radiation Therapy Oncology Group (RTOG) protocols for nonsmall cell lung cancer (Q40978262)

25 September 2017

title

The evolution of Radiation Therapy Oncology Group (RTOG) protocols for nonsmall cell lung cancer (English)

1 reference

25 September 2017

The Evolution of Radiation Therapy Oncology Group (RTOG) protocols for nonsmall cell lung cancer (English)

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

27 June 2024

author name string

R. W. Byhardt

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7635796

27 June 2024

language of work or name

English

0 references

publication date

1 July 1995

1 reference

25 September 2017

30 July 1995

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7635796

full work available at URL

27 June 2024

https://api.elsevier.com/content/article/PII:036030169500084C?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

https://api.elsevier.com/content/article/PII:036030169500084C?httpAccept=text/plain

27 June 2024

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

International Journal of Radiation Oncology Biology Physics

27 June 2024

published in

1 reference

25 September 2017

volume

32

1 reference

25 September 2017

issue

5

1 reference

25 September 2017

page(s)

1513-1525

1 reference

25 September 2017

cites work

Cancer statistics, 1994.

3

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

Concurrent Radiotherapy and Chemotherapy for Locally Advanced Non-Small-Cell Cancer of the Lung Report of a Clinical Trial and Review of the Literature

27 June 2024

4

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

The influence of field size and other treatment factors on pulmonary toxicity following hyperfractionated irradiation for inoperable non-small cell lung cancer (NSCLC)--analysis of a Radiation Therapy Oncology Group (RTOG) protocol

27 June 2024

5

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

A phase I/II study to evaluate accelerated fractionation via concomitant boost for squamous, adeno, and large cell carcinoma of the lung: report of Radiation Therapy Oncology Group 84-07

27 June 2024

6

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

Large-dose fractionation (hypofractionation).

27 June 2024

9

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

Fractionation: a paradigm for clinical research in radiation oncology.

27 June 2024

10

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

Interruptions of high-dose radiation therapy decrease long-term survival of favorable patients with unresectable non-small cell carcinoma of the lung: analysis of 1244 cases from 3 Radiation Therapy Oncology Group (RTOG) trials

27 June 2024

12

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

Five-year survival after hyperfractionated radiation therapy for non-small-cell carcinoma of the lung (NSCCL): results of RTOG protocol 81-08.

27 June 2024

13

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: possible survival benefit with greater than or equal to 69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-sm

27 June 2024

14

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

N2 (clinical) non-small cell carcinoma of the lung: prospective trials of radiation therapy with total doses 60 GY by the radiation therapy oncology group

27 June 2024

15

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

Randomized dose-searching phase ILE/II trials of fractionation in radiation therapy for cancer

27 June 2024

17

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer

27 June 2024

18

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

Phase I/II study of treatment of locally advanced (T3T4) non-oat cell lung cancer with high dose radiotherapy (rapid fractionation): Radiation Therapy Oncology Group Study

27 June 2024

20

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

Carcinoma of the lung: Hyperfractionation or resection and chemotherapy?

27 June 2024

22

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

The Janeway Lecture 1992. Nine decades of radiobiology: is radiation therapy any the better for it?

27 June 2024

27

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

Initial experience with a practical hyperfractionated accelerated radiotherapy regimen

27 June 2024

28

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

Report of phase II trial of concurrent chemoradiotherapy with radical thoracic irradiation (60 Gy), infusional fluorouracil, bolus cisplatin and etoposide for clinical stage IIIB and bulky IIIA non-small cell lung cancer.

27 June 2024

29

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

Levamisole in a phase I trial

27 June 2024

31

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx. Part 2. Normal tissue responses: acute and late effects

27 June 2024

32

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

The effects of preoperative chemotherapy on the resectability of non-small cell lung carcinoma with mediastinal lymph node metastases (N2 M0).

27 June 2024

34

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

Combined Betaseron R (recombinant human interferon beta) and radiation for inoperable non-small cell lung cancer

27 June 2024

35

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

The importance of surgery to non-small cell carcinoma of lung with mediastinal lymph node metastasis

27 June 2024

36

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

Impact of tumor control on survival in carcinoma of the lung treated with irradiation

27 June 2024

37

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

Thoracic irradiation with or without levamisole (NSC #177023) in unresectable non-small cell carcinoma of the lung: a phase III randomized trial of the RTOG

27 June 2024

38

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy. Report by the Radiation Therapy Oncology Group.

27 June 2024

39

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non-oat-cell carcinoma of the lung. Preliminary report by the Radiation Therapy Oncology Group

27 June 2024

40

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

Cell proliferation in EMT6 tumors treated with single doses of x-rays or hydroxyurea. I. Experimental results

27 June 2024

42

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

Continuous, hyperfractionated, accelerated radiotherapy (CHART) in non-small cell carcinoma of the bronchus

27 June 2024

43

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

Phase II Trial of Combination Chemotherapy and Irradiation in Non-Small-Cell Lung Cancer, Radiation Therapy Oncology Group 88–04

27 June 2024

45

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer

27 June 2024

46

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

Hyperfractionation in the radiation therapy of unresectable non-oat cell carcinoma of the lung: preliminary report of a RTOG Pilot Study

27 June 2024

48

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

Large fraction irradiation with or without misonidazole in advanced non-oat cell carcinoma of the lung: a phase III randomized trial of the RTOG. Radiation Therapy Oncology Group

27 June 2024

49

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

Large fraction radiotherapy plus misonidazole for treatment of advanced lung cancer: report of a phase I/II trial

27 June 2024

50

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

Changes in early and late radiation responses with altered dose fractionation: implications for dose-survival relationships

27 June 2024

51

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

The kinetics of tumour cell proliferation and radiotherapy

27 June 2024

52

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

The hazard of accelerated tumor clonogen repopulation during radiotherapy

27 June 2024

53

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

Dose fractionation and volume effects in normal tissues and tumors

27 June 2024

54

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

27 June 2024

Identifiers

1 reference

25 September 2017

1 reference